7:03 PM
 | 
Aug 04, 2008
 |  BC Extra  |  Company News

Vivitrol approved in Russia

Alkermes (NASDAQ:ALKS) said partner Johnson & Johnson (NYSE:JNJ) received approval in Russia to market Vivitrol injectable extended-release...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >